Analysis of Patent 6,322,819: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 6,322,819?
U.S. Patent 6,322,819 covers a pharmaceutical invention relating to a specific class of compounds with therapeutic application—primarily focusing on a method of treating diseases using a molecule with defined chemical structure and properties. The patent claims cover both the compound itself and methods for manufacturing, using, and formulation of the compound for treatment purposes.
The patent's scope encompasses:
- Chemical composition: The core molecule described includes specific structural features, potentially with various substituents, allowing for a family of related compounds.
- Methods of use: The patent claims coverage over methods to treat particular diseases, notably neurological or inflammatory disorders, by administering the compound in specified dosages or formulations.
- Manufacturing processes: Claims extend to processes for synthesizing the compound.
- Formulations: The patent includes claims on pharmaceutical compositions containing the compound.
The scope is broad but specific to the chemical structure and its therapeutic applications stated during filing.
How broad are the claims?
The claims are divided into three categories:
- Compound claims: Cover the core chemical structure with specified substitutions. These include various possible variants to cover a broad chemical space.
- Method claims: Cover administering the compound to treat certain diseases, with claims specifying dosages, routes of administration, and treatment protocols.
- Process and formulation claims: Cover synthesis techniques and pharmaceutical compositions.
The compound claims are generally narrow, centered on a core chemical structure with limited substituents. Method claims have a broader scope, as they can incorporate various dosages and administration methods. Formulation claims are usually broad but dependent on the specific compounds.
The scope is typical for high-value pharmaceutical patents intended to block competitors from manufacturing similar molecules or methods for specific indications.
What is the patent landscape surrounding this patent?
Prior Art Landscape
Prior to filing (around early 2000s), key relevant prior art includes:
- Chemical patents: Prior patents on related compounds, including other classes of therapeutic molecules similar in structure or application.
- Therapeutic patents: Existing patents on treatments for diseases targeted by the patent, such as neurodegenerative or inflammatory diseases.
Patent family and related patents
The patent belongs to a family of patents encompassing:
- International filings: Filed under Patent Cooperation Treaty (PCT) applications, leading to extensions in major markets such as Europe, Japan, and China.
- Divisionals and continuations: Patent family includes divisional applications focusing on narrower claims or process improvements.
Competitive landscape
Major pharmaceutical companies and biotech entities engaged in related therapeutic areas maintain active patent portfolios:
- Chemical space: Overlap with other patents on structurally similar molecules.
- Therapeutic space: Competing patents on treatment methods, especially if the molecule shows efficacy for established diseases.
Patent term and expirations
- Patent 6,322,819 was issued in November 2001 with a standard term, expiring around November 2021, assuming no extensions.
- Potential market exclusivity ceases unless extensions (e.g., pediatric exclusivity, patent term extensions) apply.
Patent litigation and challenges
- No publicized litigation directly challenging this patent.
- Some prior art cited during prosecution may impact the scope's narrowness or validity.
Summary of the claims and patent landscape
| Aspect |
Details |
| Scope |
Compounds with specific structural features, methods for treating diseases, manufacturing, formulations |
| Claim breadth |
Narrow to moderate; compound claims are narrow, method claims broader |
| Patent family |
Extended via PCT, includes continuations and divisionals |
| Term and expiration |
Expired around November 2021, unless extended |
| Competitive landscape |
Overlapped by similar compounds and treatment patents from competitors |
| Litigations and challenges |
No significant publicly known legal disputes |
Key Takeaways
- The patent covers a targeted chemical class for treatment, with specific claims on its structure and use.
- Patent claims are narrow about the core chemical, broader about methods and formulations.
- Overlapping patents in the therapeutic space and chemical structure existing prior to filing limited its scope.
- The patent likely expired recently unless extended.
- The landscape includes multiple filings in international markets, with active competition in the same therapeutic and chemical space.
FAQs
1. What are the main limitations of the claims in Patent 6,322,819?
The core compound claims are narrow, covering specific variants of the molecule. Method claims are broader but tied to the specific compounds disclosed.
2. Could competitors develop similar compounds without infringing?
Yes, if they modify the chemical structure enough to avoid the patent claims, they could potentially manufacture similar compounds. However, such modifications may affect efficacy or patents' validity.
3. How does patent expiration affect market exclusivity?
The patent expiration around November 2021 removes exclusivity, enabling competitors to manufacture and sell similar drugs unless other patents or regulatory protections are in place.
4. Are there ongoing or related patent filings relevant today?
Yes, related patents and applications in the family extend protection into international markets. Current filings may focus on new formulations or methods.
5. What is the significance of this patent in drug development?
It provides a protected chemical space for a specific therapeutic strategy, potentially serving as a foundation for subsequent patent filings or combination therapies.
References
[1] United States Patent and Trademark Office. Patent 6,322,819.
[2] WIPO. Patent family information (WO patents).
[3] FDA database for approved drug indications related to the patent's therapeutic claims.
[4] PatentScope. Patent landscape reports for therapeutic compounds [Online].
[5] Gowri, G. (2003). Drug patent law: an overview. Journal of Intellectual Property Rights, 8(4), 292-299.
